Methimazole drug information

Why is this medication prescribed?
How should this medicine be used?
What special precautions should I follow?
What special dietary instructions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What should I know about STORAGE and DISPOSAL of this medication?
What should I do in case of OVERDOSE?
What OTHER INFORMATION should I know?
Drug interactions

Why is this medication prescribed?

Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

How should this medicine be used?

Methimazole comes as a tablet and usually is taken three times a day, approximately every 8 hours, with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

What special precautions should I follow?

Before taking methimazole,

tell your doctor and pharmacist if you are allergic to methimazol, lactose, or any other drugs.

tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially anticoagulants ('blood thinners') such as warfarin (Coumadin), beta blockers such as propranolol (Inderal), diabetes medications, digoxin (Lanoxin), theophylline (Theobid, Theo-Dur), and vitamins.

tell your doctor if you have or have ever had any blood disease, such as decreased white blood cells (leukopenia), decreased platelets (thrombocytopenia), or aplastic anemia, or liver disease (hepatitis, jaundice).

tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. Methimazole should not be used during pregnancy or breast-feeding. If you become pregnant while taking methimazole, call your doctor immediately. Methimazole may harm the fetus.

if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking methimazole.

What special dietary instructions should I follow?

Methimazole may cause an upset stomach. Take methimazole with food or milk.

What should I do if I forget a dose?

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule at evenly spaced, 8-hour intervals. Do not take a double dose to make up for a missed one.

What side effects can this medication cause?

Methimazole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- skin rash
- itching
- abnormal hair loss
- upset stomach
- vomiting
- loss of taste
- abnormal sensations (tingling, prickling, burning, tightness, and pulling)
- swelling
- joint and muscle pain
- drowsiness
- dizziness
- decreased white blood cells
- decreased platelets

If you experience any of the following symptoms, call your doctor immediately:
- sore throat
- fever
- headache
- chills
- unusual bleeding or bruising
- right-sided abdominal pain with decreased appetite
- yellowing of the skin or eyes
- skin eruptions
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I know about STORAGE and DISPOSAL of this medication?

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

What should I do in case of OVERDOSE?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

What OTHER INFORMATION should I know?

Keep all appointments with your doctor and the laboratory.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug interactions

Drug	Interaction
Montelukast	Montelukast The metabolism of Montelukast can be decreased when combined with Methimazole.
Leflunomide	Leflunomide The risk or severity of adverse effects can be increased when Methimazole is combined with Leflunomide.
Delavirdine	Delavirdine The metabolism of Delavirdine can be decreased when combined with Methimazole.
Nevirapine	Nevirapine The metabolism of Nevirapine can be decreased when combined with Methimazole.
Atorvastatin	Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Methimazole.
Dolasetron	Dolasetron The metabolism of Dolasetron can be decreased when combined with Methimazole.
Aminophylline	Aminophylline Methimazole may decrease the excretion rate of Aminophylline which could result in a higher serum level.
Anagrelide	Anagrelide The metabolism of Anagrelide can be decreased when combined with Methimazole.
Candesartan	Candesartan The metabolism of Candesartan can be decreased when combined with Methimazole.
Cilostazol	Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Methimazole.
Clopidogrel	Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Methimazole.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.
Fenofibrate	Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Methimazole.
Guanfacine	Guanfacine The metabolism of Guanfacine can be decreased when combined with Methimazole.
Magnesium Hydroxide	Magnesium Hydroxide Methimazole may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate	Mycophenolate The risk or severity of adverse effects can be increased when Methimazole is combined with Mycophenolic acid.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Penbutolol	Penbutolol The excretion of Acebutolol can be decreased when combined with Methimazole.
Potassium	Potassium Potassium may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Methimazole may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.
Ranitidine	Ranitidine The metabolism of Ranitidine can be decreased when combined with Methimazole.
Reserpine	Reserpine Reserpine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Rizatriptan	Rizatriptan Methimazole may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan	Sumatriptan Sumatriptan may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tacrolimus	Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Methimazole.
Tizanidine	Tizanidine The metabolism of Tizanidine can be decreased when combined with Methimazole.
Triamcinolone	Triamcinolone The metabolism of Methimazole can be decreased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Methimazole.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Methimazole which could result in a higher serum level.
Fluconazole Injection	Fluconazole Injection Fluconazole may decrease the excretion rate of Methimazole which could result in a higher serum level.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Methimazole which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Methimazole.
Interferon Beta-1b Injection	Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Methimazole.
Interferon Gamma-1b Injection	Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methimazole.
Levofloxacin Injection	Levofloxacin Injection Methimazole may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection	Meperidine Injection The metabolism of Meperidine can be decreased when combined with Methimazole.
Methylprednisolone Injection	Methylprednisolone Injection The metabolism of Methylprednisolone can be decreased when combined with Methimazole.
Metoclopramide Injection	Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Methimazole.
Metronidazole Injection	Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Methimazole.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Methimazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection	Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Methimazole.
Altretamine	Altretamine The metabolism of Methimazole can be decreased when combined with Amphetamine.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cyclosporine	Cyclosporine Methimazole may increase the immunosuppressive activities of Cyclosporine.
Ondansetron	Ondansetron The metabolism of Ondansetron can be decreased when combined with Methimazole.
Enoxaparin Injection	Enoxaparin Injection Methimazole may increase the anticoagulant activities of Enoxaparin.
Torsemide	Torsemide The metabolism of Torasemide can be decreased when combined with Methimazole.
Olanzapine	Olanzapine The metabolism of Olanzapine can be decreased when combined with Methimazole.
Alosetron	Alosetron The metabolism of Alosetron can be decreased when combined with Methimazole.
Dofetilide	Dofetilide The metabolism of Dofetilide can be decreased when combined with Methimazole.
Hydroxychloroquine	Hydroxychloroquine The risk or severity of adverse effects can be increased when Methimazole is combined with Hydroxychloroquine.
Meloxicam	Meloxicam The metabolism of Meloxicam can be decreased when combined with Methimazole.
Pantoprazole	Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Methimazole.
Temozolomide	Temozolomide The risk or severity of adverse effects can be increased when Methimazole is combined with Temozolomide.
Zaleplon	Zaleplon Methimazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra	Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.
Linezolid	Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Methimazole.
Pentosan Polysulfate	Pentosan Polysulfate Methimazole may increase the anticoagulant activities of Pentosan polysulfate.
Trimipramine	Trimipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Trimipramine.
Etanercept Injection	Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.
Perindopril	Perindopril Methimazole may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir	Tenofovir The metabolism of Methimazole can be decreased when combined with Tenofovir.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sirolimus	Sirolimus The metabolism of Sirolimus can be decreased when combined with Methimazole.
Epinephrine Injection	Epinephrine Injection The risk or severity of adverse effects can be increased when Epinephrine is combined with Methimazole.
Epirubicin	Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Methimazole.
Eplerenone	Eplerenone The metabolism of Methimazole can be decreased when combined with Eplerenone.
Escitalopram	Escitalopram The metabolism of Escitalopram can be decreased when combined with Methimazole.
Zonisamide	Zonisamide The metabolism of Zonisamide can be decreased when combined with Methimazole.
Adalimumab Injection	Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.
Aripiprazole	Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Methimazole.
Atomoxetine	Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Methimazole.
Glatiramer Injection	Glatiramer Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Glatiramer.
Atazanavir	Atazanavir The metabolism of Atazanavir can be decreased when combined with Methimazole.
Almotriptan	Almotriptan The metabolism of Almotriptan can be decreased when combined with Methimazole.
Eletriptan	Eletriptan The metabolism of Eletriptan can be decreased when combined with Methimazole.
Rosuvastatin	Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Methimazole.
Vardenafil	Vardenafil The metabolism of Vardenafil can be decreased when combined with Methimazole.
Alfuzosin	Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Methimazole.
Emtricitabine	Emtricitabine Methimazole may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine	Memantine Methimazole may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod	Tegaserod The metabolism of Tegaserod can be decreased when combined with Methimazole.
Tadalafil	Tadalafil The serum concentration of Tadalafil can be increased when it is combined with Methimazole.
Frovatriptan	Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Methimazole.
Progesterone	Progesterone The metabolism of Progesterone can be decreased when combined with Methimazole.
Apomorphine Injection	Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Methimazole.
Infliximab Injection	Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Methimazole.
Protriptyline	Protriptyline The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Protriptyline.
Duloxetine	Duloxetine The metabolism of Duloxetine can be decreased when combined with Methimazole.
Norethindrone	Norethindrone The metabolism of Norethisterone can be decreased when combined with Methimazole.
Tinidazole	Tinidazole Methimazole may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan	Bosentan The metabolism of Bosentan can be decreased when combined with Methimazole.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cinacalcet	Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Methimazole.
Natalizumab Injection	Natalizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Natalizumab.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Erlotinib can be decreased when combined with Methimazole.
Eszopiclone	Eszopiclone The serum concentration of Eszopiclone can be increased when it is combined with Methimazole.
Ganciclovir	Ganciclovir Methimazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Palifermin	Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.
Ribavirin	Ribavirin Methimazole may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin	Solifenacin The metabolism of Solifenacin can be decreased when combined with Methimazole.
Valganciclovir	Valganciclovir Methimazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole	Voriconazole The metabolism of Voriconazole can be decreased when combined with Methimazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine The metabolism of Methimazole can be decreased when combined with Amphetamine.
Entecavir	Entecavir The metabolism of Entecavir can be decreased when combined with Methimazole.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.
Ramelteon	Ramelteon The metabolism of Ramelteon can be decreased when combined with Methimazole.
Darifenacin	Darifenacin The metabolism of Darifenacin can be decreased when combined with Methimazole.
Fentanyl	Fentanyl The metabolism of Fentanyl can be decreased when combined with Methimazole.
Pregabalin	Pregabalin Pregabalin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Phenylephrine	Phenylephrine The risk or severity of adverse effects can be increased when Phenylephrine is combined with Methimazole.
Tipranavir	Tipranavir The metabolism of Tipranavir can be decreased when combined with Methimazole.
Felbamate	Felbamate The metabolism of Felbamate can be decreased when combined with Methimazole.
Ranolazine	Ranolazine The metabolism of Ranolazine can be decreased when combined with Methimazole.
Abatacept Injection	Abatacept Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Abatacept.
Rasagiline	Rasagiline The metabolism of Rasagiline can be decreased when combined with Methimazole.
Imatinib	Imatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Imatinib.
Sitagliptin	Sitagliptin Methimazole may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline	Varenicline Methimazole may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection	Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Methimazole.
Gefitinib	Gefitinib The therapeutic efficacy of Gefitinib can be decreased when used in combination with Methimazole.
Albuterol	Albuterol Methimazole may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone	Paliperidone The metabolism of Paliperidone can be decreased when combined with Methimazole.
Bortezomib	Bortezomib The metabolism of Methimazole can be decreased when combined with Bortezomib.
Clofarabine Injection	Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Methimazole.
Hepatitis B Vaccine	Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Methimazole.
Influenza Vaccine, Inactivated or Recombinant	Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Methimazole.
Influenza Vaccine, Live Intranasal	Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Methimazole.
Live Shingles (Zoster) Vaccine (ZVL)	Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Methimazole.
Lubiprostone	Lubiprostone Methimazole may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection	Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Methimazole.
Primaquine	Primaquine The metabolism of Primaquine can be decreased when combined with Methimazole.
Rituximab Injection	Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Methimazole.
Pemetrexed Injection	Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Methimazole.
Lisdexamfetamine	Lisdexamfetamine The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Methimazole.
Retapamulin	Retapamulin The metabolism of Retapamulin can be decreased when combined with Methimazole.
Vorinostat	Vorinostat The risk or severity of adverse effects can be increased when Methimazole is combined with Vorinostat.
Sorafenib	Sorafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Sorafenib.
Sunitinib	Sunitinib The therapeutic efficacy of Sunitinib can be decreased when used in combination with Methimazole.
Dronabinol	Dronabinol The metabolism of Dronabinol can be decreased when combined with Methimazole.
Lapatinib	Lapatinib The metabolism of Lapatinib can be decreased when combined with Methimazole.
Levocetirizine	Levocetirizine Methimazole may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection	Pegaptanib Injection Methimazole may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Dasatinib can be decreased when combined with Methimazole.
Mexiletine	Mexiletine The metabolism of Mexiletine can be decreased when combined with Methimazole.
Azacitidine Injection	Azacitidine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Azacitidine.
Temsirolimus	Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Methimazole.
Maraviroc	Maraviroc The metabolism of Maraviroc can be decreased when combined with Methimazole.
Nelarabine Injection	Nelarabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Nelarabine.
Lenalidomide	Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Methimazole.
Nilotinib	Nilotinib The metabolism of Nilotinib can be decreased when combined with Methimazole.
Bexarotene	Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Methimazole.
Budesonide	Budesonide The metabolism of Budesonide can be decreased when combined with Methimazole.
Chloramphenicol Injection	Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methimazole.
Decitabine Injection	Decitabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Decitabine.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Doripenem Injection	Doripenem Injection Methimazole may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine	Etravirine The metabolism of Etravirine can be decreased when combined with Methimazole.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Arsenic trioxide.
Mitoxantrone Injection	Mitoxantrone Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Mitoxantrone.
Desvenlafaxine	Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cevimeline	Cevimeline The metabolism of Cevimeline can be decreased when combined with Methimazole.
Nebivolol	Nebivolol The excretion of Nebivolol can be decreased when combined with Methimazole.
Tretinoin	Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Methimazole.
Bendamustine Injection	Bendamustine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Bendamustine.
Flecainide	Flecainide The metabolism of Flecainide can be decreased when combined with Methimazole.
Certolizumab Injection	Certolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Certolizumab pegol.
Ixabepilone Injection	Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Methimazole.
Irinotecan Injection	Irinotecan Injection The serum concentration of SN-38, an active metabolite of Methimazole, can be increased when used in combination with Irinotecan.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Estramustine	Estramustine The risk or severity of adverse effects can be increased when Methimazole is combined with Estramustine.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Methimazole.
Methylnaltrexone Injection	Methylnaltrexone Injection Methimazole may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia)	Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Methimazole.
Rufinamide	Rufinamide The metabolism of Rufinamide can be decreased when combined with Methimazole.
Midazolam	Midazolam The serum concentration of Midazolam can be increased when it is combined with Methimazole.
Dexrazoxane Injection	Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Methimazole.
Eltrombopag	Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Methimazole.
Ibritumomab Injection	Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Methimazole.
Milnacipran	Milnacipran The metabolism of Milnacipran can be decreased when combined with Methimazole.
Dexlansoprazole	Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Methimazole.
Plerixafor Injection	Plerixafor Injection Methimazole may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine	Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Methimazole.
Betaxolol	Betaxolol The excretion of Betaxolol can be decreased when combined with Methimazole.
Iloperidone	Iloperidone The metabolism of Iloperidone can be decreased when combined with Methimazole.
Prasugrel	Prasugrel The metabolism of Prasugrel can be decreased when combined with Methimazole.
Lacosamide	Lacosamide The metabolism of Lacosamide can be decreased when combined with Methimazole.
Everolimus	Everolimus The metabolism of Everolimus can be decreased when combined with Methimazole.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) The metabolism of Methimazole can be decreased when combined with Tolvaptan.
Dronedarone	Dronedarone The metabolism of Dronedarone can be decreased when combined with Methimazole.
Pralatrexate Injection	Pralatrexate Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Pralatrexate.
Palonosetron Injection	Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Methimazole.
Saxagliptin	Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Methimazole.
Telavancin Injection	Telavancin Injection Methimazole may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection	Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Methimazole.
Tapentadol	Tapentadol The metabolism of Tapentadol can be decreased when combined with Methimazole.
Topotecan	Topotecan The risk or severity of adverse effects can be increased when Methimazole is combined with Topotecan.
Golimumab Injection	Golimumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Golimumab.
Pazopanib	Pazopanib The metabolism of Pazopanib can be decreased when combined with Methimazole.
Asenapine	Asenapine The metabolism of Asenapine can be decreased when combined with Methimazole.
Pitavastatin	Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Methimazole.
Albendazole	Albendazole The metabolism of Albendazole can be decreased when combined with Methimazole.
Oxymorphone	Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Methimazole.
Denosumab Injection	Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Methimazole.
Dabigatran	Dabigatran Methimazole may increase the anticoagulant activities of Dabigatran.
Tocilizumab Injection	Tocilizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Tocilizumab.
Dalfampridine	Dalfampridine Methimazole may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod	Fingolimod Methimazole may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection	Eribulin Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Eribulin.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Methimazole.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Acetaminophen Injection	Acetaminophen Injection Methimazole may increase the hepatotoxic activities of Acetaminophen.
Vilazodone	Vilazodone The metabolism of Vilazodone can be decreased when combined with Methimazole.
Ipilimumab Injection	Ipilimumab Injection Methimazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.
Sipuleucel-T Injection	Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Methimazole.
Terbutaline Injection	Terbutaline Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Terbutaline.
Belimumab Injection	Belimumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belimumab.
Busulfan Injection	Busulfan Injection The metabolism of Busulfan can be decreased when combined with Methimazole.
Roflumilast	Roflumilast Roflumilast may increase the immunosuppressive activities of Methimazole.
Linagliptin	Linagliptin The metabolism of Linagliptin can be decreased when combined with Methimazole.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Methimazole can be decreased when combined with Cyclophosphamide.
Rivaroxaban	Rivaroxaban Methimazole may increase the anticoagulant activities of Rivaroxaban.
Ticagrelor	Ticagrelor Methimazole may increase the anticoagulant activities of Ticagrelor.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Methimazole.
Ruxolitinib	Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Methimazole.
Vandetanib	Vandetanib The therapeutic efficacy of Methimazole can be decreased when used in combination with Vandetanib.
Clobazam	Clobazam The metabolism of Clobazam can be decreased when combined with Methimazole.
Vemurafenib	Vemurafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Vemurafenib.
Vismodegib	Vismodegib The metabolism of Vismodegib can be decreased when combined with Methimazole.
Belatacept Injection	Belatacept Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belatacept.
Ivacaftor	Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Methimazole.
Basiliximab Injection	Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Methimazole.
Deferiprone	Deferiprone Methimazole may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Methimazole.
Crizotinib	Crizotinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Crizotinib.
Melphalan Injection	Melphalan Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Melphalan.
Cabergoline	Cabergoline The metabolism of Cabergoline can be decreased when combined with Methimazole.
Naloxone Injection	Naloxone Injection Methimazole may decrease the excretion rate of Naloxone which could result in a higher serum level.
Eculizumab Injection	Eculizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Eculizumab.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may increase the anticoagulant activities of Methimazole.
Carfilzomib Injection	Carfilzomib Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Carfilzomib.
Iloprost	Iloprost Methimazole may increase the anticoagulant activities of Iloprost.
Enzalutamide	Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Methimazole.
Mirabegron	Mirabegron The metabolism of Mirabegron can be decreased when combined with Methimazole.
Regorafenib	Regorafenib The therapeutic efficacy of Methimazole can be decreased when used in combination with Regorafenib.
Bosutinib	Bosutinib The therapeutic efficacy of Bosutinib can be decreased when used in combination with Methimazole.
Corticotropin, Repository Injection	Corticotropin, Repository Injection The metabolism of Corticotropin can be decreased when combined with Methimazole.
Teriflunomide	Teriflunomide The risk or severity of adverse effects can be increased when Methimazole is combined with Teriflunomide.
Cabozantinib (thyroid cancer)	Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Methimazole.
Teduglutide Injection	Teduglutide Injection Methimazole may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline	Bedaquiline The metabolism of Bedaquiline can be decreased when combined with Methimazole.
Icosapent Ethyl	Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Methimazole.
Tofacitinib	Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Methimazole.
Alogliptin	Alogliptin The metabolism of Alogliptin can be decreased when combined with Methimazole.
Dimethyl Fumarate	Dimethyl Fumarate The risk or severity of adverse effects can be increased when Methimazole is combined with Dimethyl fumarate.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Methimazole.
Pomalidomide	Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Methimazole.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Methimazole.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Methimazole.
Canagliflozin	Canagliflozin Canagliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Methimazole.
Ospemifene	Ospemifene The metabolism of Ospemifene can be decreased when combined with Methimazole.
Trametinib	Trametinib Methimazole may decrease the excretion rate of Trametinib which could result in a higher serum level.
Afatinib	Afatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Afatinib.
Levomilnacipran	Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Methimazole.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Methimazole which could result in a higher serum level.
Vortioxetine	Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Methimazole.
Perampanel	Perampanel The metabolism of Perampanel can be decreased when combined with Methimazole.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Methimazole.
Lomitapide	Lomitapide The metabolism of Lomitapide can be decreased when combined with Methimazole.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Obinutuzumab Injection	Obinutuzumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Obinutuzumab.
Sofosbuvir	Sofosbuvir Methimazole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Methimazole.
Apremilast	Apremilast The risk or severity of adverse effects can be increased when Methimazole is combined with Apremilast.
Droxidopa	Droxidopa Methimazole may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib	Ceritinib The metabolism of Methimazole can be decreased when combined with Ceritinib.
Siltuximab Injection	Siltuximab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Siltuximab.
Vedolizumab Injection	Vedolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Vedolizumab.
Belinostat Injection	Belinostat Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Belinostat.
Idelalisib	Idelalisib The metabolism of Idelalisib can be decreased when combined with Methimazole.
Testosterone Injection	Testosterone Injection The metabolism of Testosterone can be decreased when combined with Methimazole.
Vorapaxar	Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Methimazole.
Hydrocodone	Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Methimazole.
Suvorexant	Suvorexant The metabolism of Suvorexant can be decreased when combined with Methimazole.
Edoxaban	Edoxaban Methimazole may increase the anticoagulant activities of Edoxaban.
Peginterferon Beta-1a Injection	Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Peginterferon beta-1a.
Olaparib	Olaparib The metabolism of Olaparib can be decreased when combined with Methimazole.
Blinatumomab Injection	Blinatumomab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Blinatumomab.
Methamphetamine	Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Methimazole.
Tasimelteon	Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Methimazole.
Riociguat	Riociguat The serum concentration of Riociguat can be increased when it is combined with Methimazole.
Pirfenidone	Pirfenidone The risk or severity of adverse effects can be increased when Methimazole is combined with Pirfenidone.
Nintedanib	Nintedanib The therapeutic efficacy of Methimazole can be decreased when used in combination with Nintedanib.
Secukinumab Injection	Secukinumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Secukinumab.
Risperidone Injection	Risperidone Injection The metabolism of Risperidone can be decreased when combined with Methimazole.
Palbociclib	Palbociclib The metabolism of Palbociclib can be decreased when combined with Methimazole.
Lenvatinib	Lenvatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Lenvatinib.
Panobinostat	Panobinostat The metabolism of Panobinostat can be decreased when combined with Methimazole.
Dinutuximab Injection	Dinutuximab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Dinutuximab.
Haloperidol Injection	Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Methimazole.
Amiloride	Amiloride Amiloride may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection	Isavuconazonium Injection The serum concentration of Isavuconazonium can be increased when it is combined with Methimazole.
Macitentan	Macitentan Methimazole may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib	Sonidegib The metabolism of Sonidegib can be decreased when combined with Methimazole.
Flibanserin	Flibanserin The metabolism of Flibanserin can be decreased when combined with Methimazole.
Prednisolone	Prednisolone Methimazole may increase the excretion rate of Prednisolone which could result in a lower serum level and potentially a reduction in efficacy.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Methimazole.
Brexpiprazole	Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Methimazole.
Ziprasidone Injection	Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Methimazole.
Cariprazine	Cariprazine The metabolism of Cariprazine can be decreased when combined with Methimazole.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Methimazole may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Cobimetinib	Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Methimazole.
Mepolizumab Injection	Mepolizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Mepolizumab.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Methimazole.
Osimertinib	Osimertinib The metabolism of Methimazole can be decreased when combined with Osimertinib.
Alectinib	Alectinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Alectinib.
Ixazomib	Ixazomib The metabolism of Ixazomib can be decreased when combined with Methimazole.
Lesinurad	Lesinurad The metabolism of Lesinurad can be decreased when combined with Methimazole.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Dexamethasone can be decreased when combined with Methimazole.
Defibrotide Injection	Defibrotide Injection Methimazole may increase the anticoagulant activities of Defibrotide.
Ixekizumab Injection	Ixekizumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Ixekizumab.
Brivaracetam Injection	Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Methimazole.
Venetoclax	Venetoclax The metabolism of Venetoclax can be decreased when combined with Methimazole.
Midodrine	Midodrine The risk or severity of adverse effects can be increased when Midodrine is combined with Methimazole.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Methimazole.
Furosemide Injection	Furosemide Injection Furosemide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib	Rucaparib The metabolism of Rucaparib can be decreased when combined with Methimazole.
Lixisenatide Injection	Lixisenatide Injection Methimazole may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib	Ribociclib The metabolism of Ribociclib can be decreased when combined with Methimazole.
Brodalumab Injection	Brodalumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Brodalumab.
Brigatinib	Brigatinib The metabolism of Methimazole can be decreased when combined with Brigatinib.
Doxepin (Insomnia)	Doxepin (Insomnia) The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Doxepin.
Deutetrabenazine	Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Methimazole.
Valbenazine	Valbenazine The metabolism of Valbenazine can be decreased when combined with Methimazole.
Deflazacort	Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Methimazole.
Ocrelizumab Injection	Ocrelizumab Injection Methimazole may increase the immunosuppressive activities of Ocrelizumab.
Naldemedine	Naldemedine Methimazole may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection	Sarilumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Sarilumab.
Midostaurin	Midostaurin The therapeutic efficacy of Methimazole can be decreased when used in combination with Midostaurin.
Neratinib	Neratinib The serum concentration of Methimazole can be increased when it is combined with Neratinib.
Guselkumab Injection	Guselkumab Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Guselkumab.
Enasidenib	Enasidenib The metabolism of Enasidenib can be decreased when combined with Methimazole.
Aprepitant/Fosaprepitant Injection	Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Methimazole.
Benznidazole	Benznidazole Methimazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Methimazole.
Delafloxacin	Delafloxacin Methimazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib	Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Methimazole.
Betrixaban	Betrixaban Methimazole may increase the anticoagulant activities of Betrixaban.
Acalabrutinib	Acalabrutinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Acalabrutinib.
Gemtuzumab Ozogamicin Injection	Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methimazole.
Letermovir	Letermovir The metabolism of Letermovir can be decreased when combined with Methimazole.
Tetrabenazine	Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Methimazole.
Ertugliflozin	Ertugliflozin Ertugliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection	Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Methimazole.
Apalutamide	Apalutamide The metabolism of Apalutamide can be decreased when combined with Methimazole.
Penicillamine	Penicillamine The risk or severity of adverse effects can be increased when Methimazole is combined with Penicillamine.
Fostamatinib	Fostamatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Fostamatinib.
Baricitinib	Baricitinib The metabolism of Baricitinib can be decreased when combined with Methimazole.
Lofexidine	Lofexidine The metabolism of Lofexidine can be decreased when combined with Methimazole.
Plazomicin Injection	Plazomicin Injection Methimazole may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat	Eliglustat The metabolism of Eliglustat can be decreased when combined with Methimazole.
Encorafenib	Encorafenib The metabolism of Encorafenib can be decreased when combined with Methimazole.
Binimetinib	Binimetinib The metabolism of Binimetinib can be decreased when combined with Methimazole.
Ivosidenib	Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Methimazole.
Elagolix	Elagolix The metabolism of Elagolix can be decreased when combined with Methimazole.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Methimazole.
Cannabidiol	Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Methimazole.
Dacomitinib	Dacomitinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Dacomitinib.
Duvelisib	Duvelisib The metabolism of Duvelisib can be decreased when combined with Methimazole.
Stiripentol	Stiripentol The metabolism of Stiripentol can be decreased when combined with Methimazole.
Gilteritinib	Gilteritinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Gilteritinib.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Methimazole.
Larotrectinib	Larotrectinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Larotrectinib.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Methimazole.
Prucalopride	Prucalopride The metabolism of Prucalopride can be decreased when combined with Methimazole.
Ravulizumab-cwvz Injection	Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Ravulizumab.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Emapalumab.
Siponimod	Siponimod The risk or severity of adverse effects can be increased when Methimazole is combined with Siponimod.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Caplacizumab-yhdp Injection	Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Methimazole.
Erdafitinib	Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Methimazole.
Esomeprazole Injection	Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Methimazole.
Risankizumab-rzaa Injection	Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Risankizumab.
Alpelisib	Alpelisib The metabolism of Alpelisib can be decreased when combined with Methimazole.
Cladribine	Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Methimazole.
Polatuzumab vedotin-piiq Injection	Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Polatuzumab vedotin.
Solriamfetol	Solriamfetol Methimazole may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide	Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Methimazole.
Triclabendazole	Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Methimazole.
Entrectinib	Entrectinib The metabolism of Methimazole can be decreased when combined with Entrectinib.
Pexidartinib	Pexidartinib The metabolism of Methimazole can be decreased when combined with Pexidartinib.
Upadacitinib	Upadacitinib The metabolism of Upadacitinib can be decreased when combined with Methimazole.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Methimazole.
Pitolisant	Pitolisant The metabolism of Pitolisant can be decreased when combined with Methimazole.
Pretomanid	Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Methimazole.
Fedratinib	Fedratinib The therapeutic efficacy of Fedratinib can be decreased when used in combination with Methimazole.
Lefamulin	Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Methimazole.
Phenytoin Injection	Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Methimazole.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Methimazole.
Enfortumab vedotin-ejfv Injection	Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Methimazole.
Zanubrutinib	Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Methimazole.
Voxelotor	Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Methimazole.
Avapritinib	Avapritinib The metabolism of Avapritinib can be decreased when combined with Methimazole.
Lumateperone	Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Methimazole.
Ubrogepant	Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Methimazole.
Tazemetostat	Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Methimazole.
Cenobamate	Cenobamate The metabolism of Cenobamate can be decreased when combined with Methimazole.
Pemigatinib	Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Methimazole.
Ozanimod	Ozanimod The risk or severity of adverse effects can be increased when Methimazole is combined with Ozanimod.
Selumetinib	Selumetinib The serum concentration of Methimazole can be increased when it is combined with Selumetinib.
Rimegepant	Rimegepant The metabolism of Rimegepant can be decreased when combined with Methimazole.
Tucatinib	Tucatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Tucatinib.
Ripretinib	Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Methimazole.
Selpercatinib	Selpercatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Selpercatinib.
Capmatinib	Capmatinib The therapeutic efficacy of Methimazole can be decreased when used in combination with Capmatinib.
Lurbinectedin Injection	Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Methimazole.
Pralsetinib	Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Methimazole.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Methimazole can be decreased when combined with Drospirenone.
Viloxazine	Viloxazine Methimazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Theophylline	Theophylline The excretion of Theophylline can be decreased when combined with Methimazole.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Indomethacin	Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Methimazole.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Trazodone	Trazodone The serum concentration of Trazodone can be increased when it is combined with Methimazole.
Isotretinoin	Isotretinoin Methimazole may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Hydroxyurea	Hydroxyurea The risk or severity of adverse effects can be increased when Methimazole is combined with Hydroxyurea.
Floxuridine	Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Methimazole.
Phenobarbital	Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Methimazole.
Metaxalone	Metaxalone Metaxalone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Methotrexate Injection	Methotrexate Injection The metabolism of Methimazole can be decreased when combined with Methotrexate.
Primidone	Primidone The metabolism of Primidone can be decreased when combined with Methimazole.
Methsuximide	Methsuximide The metabolism of Methsuximide can be decreased when combined with Methimazole.
Diethylpropion	Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Methimazole.
Chlorpromazine	Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Methimazole.
Diazepam	Diazepam The metabolism of Diazepam can be decreased when combined with Methimazole.
Oxazepam	Oxazepam Methimazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam	Flurazepam Methimazole may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate	Clorazepate Clorazepic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Lorazepam	Lorazepam The metabolism of Methimazole can be decreased when combined with Lorazepam.
Carmustine	Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Methimazole.
Amantadine	Amantadine Methimazole may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine	Codeine The metabolism of Methimazole can be decreased when combined with Codeine.
Metaproterenol	Metaproterenol The risk or severity of adverse effects can be increased when Orciprenaline is combined with Methimazole.
Phenelzine	Phenelzine Methimazole may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine	Procarbazine The risk or severity of adverse effects can be increased when Methimazole is combined with Procarbazine.
Tetracycline	Tetracycline Tetracycline may decrease the excretion rate of Methimazole which could result in a higher serum level.
Thioguanine	Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Methimazole.
Prochlorperazine	Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Methimazole.
Thioridazine	Thioridazine The metabolism of Thioridazine can be decreased when combined with Methimazole.
Trifluoperazine	Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Methimazole.
Bleomycin	Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Methimazole.
Dapsone	Dapsone The metabolism of Dapsone can be decreased when combined with Methimazole.
Sulfadiazine	Sulfadiazine Sulfadiazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Oxycodone	Oxycodone The metabolism of Oxycodone can be decreased when combined with Methimazole.
Methadone	Methadone The metabolism of Methadone can be decreased when combined with Methimazole.
Benztropine	Benztropine The metabolism of Methimazole can be decreased when combined with Benzatropine.
Maprotiline	Maprotiline The metabolism of Maprotiline can be decreased when combined with Methimazole.
Ibuprofen	Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Methimazole.
Perphenazine	Perphenazine The metabolism of Perphenazine can be decreased when combined with Methimazole.
Azathioprine	Azathioprine The risk or severity of adverse effects can be increased when Methimazole is combined with Azathioprine.
Phentermine	Phentermine The metabolism of Methimazole can be decreased when combined with Phentermine.
Methylphenidate	Methylphenidate Methylphenidate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Amoxapine	Amoxapine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Amoxapine.
Sulfasalazine	Sulfasalazine The risk or severity of adverse effects can be increased when Methimazole is combined with Sulfasalazine.
Hydrocortisone	Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Methimazole.
Lomustine	Lomustine The risk or severity of adverse effects can be increased when Methimazole is combined with Lomustine.
Doxorubicin	Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Methimazole.
Cytarabine	Cytarabine The risk or severity of adverse effects can be increased when Methimazole is combined with Cytarabine.
Mechlorethamine	Mechlorethamine The risk or severity of adverse effects can be increased when Methimazole is combined with Mechlorethamine.
Dactinomycin	Dactinomycin The risk or severity of adverse effects can be increased when Methimazole is combined with Dactinomycin.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Carbamazepine	Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Methimazole.
Methyldopa	Methyldopa Methimazole may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine	Clonidine The metabolism of Clonidine can be decreased when combined with Methimazole.
Hydralazine	Hydralazine Methimazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine	Cimetidine Cimetidine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Warfarin	Warfarin Methimazole may decrease the anticoagulant activities of Warfarin.
Clonazepam	Clonazepam Methimazole may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide	Loperamide The metabolism of Loperamide can be decreased when combined with Methimazole.
Promethazine	Promethazine The metabolism of Promethazine can be decreased when combined with Methimazole.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Daunorubicin	Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methimazole.
Nitrofurantoin	Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Digoxin	Digoxin The serum concentration of Digoxin can be increased when it is combined with Methimazole.
Chloroquine	Chloroquine The metabolism of Chloroquine can be decreased when combined with Methimazole.
Quinine	Quinine The metabolism of Quinine can be decreased when combined with Methimazole.
Ethosuximide	Ethosuximide The metabolism of Ethosuximide can be decreased when combined with Methimazole.
Triamterene	Triamterene The metabolism of Triamterene can be decreased when combined with Methimazole.
Sulfinpyrazone	Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Methimazole.
Chlorothiazide	Chlorothiazide Chlorothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone	Metolazone Metolazone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital	Secobarbital Secobarbital may decrease the excretion rate of Methimazole which could result in a higher serum level.
Desipramine	Desipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Desipramine.
Amitriptyline	Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Methimazole.
Imipramine	Imipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Imipramine.
Probenecid	Probenecid Methimazole may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine	Quinidine The metabolism of Quinidine can be decreased when combined with Methimazole.
Procainamide	Procainamide The metabolism of Procainamide can be decreased when combined with Methimazole.
Isoniazid	Isoniazid Methimazole may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Disopyramide	Disopyramide The metabolism of Disopyramide can be decreased when combined with Methimazole.
Valproic Acid	Valproic Acid The metabolism of Valproic acid can be decreased when combined with Methimazole.
Tamoxifen	Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Methimazole.
Mitomycin	Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Methimazole.
Butabarbital	Butabarbital Butabarbital may decrease the excretion rate of Methimazole which could result in a higher serum level.
Liothyronine	Liothyronine Liothyronine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propylthiouracil	Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Methimazole.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Methimazole.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Methimazole.
Dextromethorphan	Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Methimazole.
Cyclobenzaprine	Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Methimazole.
Baclofen	Baclofen Baclofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorpheniramine	Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Methimazole.
Brompheniramine	Brompheniramine The metabolism of Brompheniramine can be decreased when combined with Methimazole.
Meclizine	Meclizine The metabolism of Meclizine can be decreased when combined with Methimazole.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Methimazole which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorzoxazone	Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Methimazole.
Carisoprodol	Carisoprodol The metabolism of Carisoprodol can be decreased when combined with Methimazole.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) The excretion of Propranolol can be decreased when combined with Methimazole.
Pseudoephedrine	Pseudoephedrine The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Methimazole.
Nortriptyline	Nortriptyline The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Nortriptyline.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.
Mercaptopurine	Mercaptopurine Methimazole may decrease the excretion rate of Mercaptopurine which could result in a higher serum level.
Phytonadione	Phytonadione Methimazole may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nadolol	Nadolol The excretion of Nadolol can be decreased when combined with Methimazole.
Allopurinol	Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Methimazole.
Flavoxate	Flavoxate Methimazole may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection	Fluorouracil Injection The metabolism of Methimazole can be decreased when combined with Fluorouracil.
Colchicine	Colchicine The metabolism of Colchicine can be decreased when combined with Methimazole.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cephalexin	Cephalexin The metabolism of Methimazole can be decreased when combined with Cephalexin.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dacarbazine	Dacarbazine The risk or severity of adverse effects can be increased when Methimazole is combined with Dacarbazine.
Acetazolamide	Acetazolamide Acetazolamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine	Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Methimazole.
Pyrantel	Pyrantel Methimazole may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection	Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Methimazole.
Vincristine Injection	Vincristine Injection The metabolism of Methimazole can be decreased when combined with Vincristine.
Dipyridamole	Dipyridamole Methimazole may increase the anticoagulant activities of Dipyridamole.
Isoxsuprine	Isoxsuprine The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Methimazole.
Vinblastine	Vinblastine The metabolism of Methimazole can be decreased when combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Metoprolol	Metoprolol The excretion of Methimazole can be decreased when combined with Metoprolol.
Thiothixene	Thiothixene The metabolism of Thiothixene can be decreased when combined with Methimazole.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorambucil	Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Methimazole.
Alprazolam	Alprazolam The metabolism of Alprazolam can be decreased when combined with Methimazole.
Temazepam	Temazepam Temazepam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Triazolam	Triazolam Methimazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine	Dicyclomine Methimazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline	Propantheline Methimazole may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim	Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Methimazole.
Diltiazem	Diltiazem The metabolism of Diltiazem can be decreased when combined with Methimazole.
Nifedipine	Nifedipine The metabolism of Nifedipine can be decreased when combined with Methimazole.
Timolol	Timolol The metabolism of Timolol can be decreased when combined with Methimazole.
Verapamil	Verapamil The metabolism of Verapamil can be decreased when combined with Methimazole.
Atenolol	Atenolol The excretion of Atenolol can be decreased when combined with Methimazole.
Pindolol	Pindolol The excretion of Pindolol can be decreased when combined with Methimazole.
Cisplatin Injection	Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Methimazole.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Methimazole which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Bumetanide	Bumetanide Methimazole may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin	Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Methimazole.
Etoposide	Etoposide The metabolism of Etoposide can be decreased when combined with Methimazole.
Glyburide	Glyburide The therapeutic efficacy of Glyburide can be decreased when used in combination with Methimazole.
Glipizide	Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Methimazole.
Indapamide	Indapamide Indapamide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin	Amoxicillin Methimazole may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection	Oxacillin Injection Oxacillin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Pentoxifylline	Pentoxifylline Methimazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Labetalol	Labetalol The excretion of Methimazole can be decreased when combined with Labetalol.
Auranofin	Auranofin Methimazole may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Gemfibrozil	Gemfibrozil Methimazole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz	Guanabenz The metabolism of Guanabenz can be decreased when combined with Methimazole.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Methimazole which could result in a higher serum level.
Pimozide	Pimozide The metabolism of Pimozide can be decreased when combined with Methimazole.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Methimazole which could result in a higher serum level.
Amiodarone	Amiodarone The therapeutic efficacy of Methimazole can be decreased when used in combination with Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Methimazole which could result in a higher serum level.
Buspirone	Buspirone The metabolism of Buspirone can be decreased when combined with Methimazole.
Lovastatin	Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Methimazole.
Ciprofloxacin	Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Diclofenac	Diclofenac The metabolism of Diclofenac can be decreased when combined with Methimazole.
Fluoxetine	Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Methimazole.
Interferon Alfa-2b Injection	Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Methimazole.
Clozapine	Clozapine The risk or severity of neutropenia can be increased when Methimazole is combined with Clozapine.
Estazolam	Estazolam Methimazole may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin	Idarubicin The risk or severity of adverse effects can be increased when Methimazole is combined with Idarubicin.
Didanosine	Didanosine Methimazole may decrease the excretion rate of Didanosine which could result in a higher serum level.
Fludarabine Injection	Fludarabine Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Fludarabine.
Pentostatin Injection	Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Methimazole.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Fosinopril	Fosinopril Fosinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Simvastatin	Simvastatin The metabolism of Simvastatin can be decreased when combined with Methimazole.
Amlodipine	Amlodipine The metabolism of Amlodipine can be decreased when combined with Methimazole.
Teniposide Injection	Teniposide Injection The metabolism of Methimazole can be decreased when combined with Teniposide.
Lisinopril	Lisinopril Lisinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Sotalol	Sotalol The excretion of Sotalol can be decreased when combined with Methimazole.
Bisoprolol	Bisoprolol The excretion of Methimazole can be decreased when combined with Bisoprolol.
Zolpidem	Zolpidem The metabolism of Zolpidem can be decreased when combined with Methimazole.
Doxazosin	Doxazosin The metabolism of Doxazosin can be decreased when combined with Methimazole.
Isradipine	Isradipine Isradipine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Omeprazole	Omeprazole The metabolism of Omeprazole can be decreased when combined with Methimazole.
Cisapride	Cisapride The metabolism of Cisapride can be decreased when combined with Methimazole.
Fluvastatin	Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Methimazole.
Venlafaxine	Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Methimazole.
Famciclovir	Famciclovir The metabolism of Famciclovir can be decreased when combined with Methimazole.
Fluvoxamine	Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Methimazole.
Nefazodone	Nefazodone The metabolism of Nefazodone can be decreased when combined with Methimazole.
Lamotrigine	Lamotrigine Lamotrigine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Losartan	Losartan The metabolism of Losartan can be decreased when combined with Methimazole.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Tramadol	Tramadol The metabolism of Tramadol can be decreased when combined with Methimazole.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Methimazole can be decreased when combined with Vinorelbine.
Carboplatin Injection	Carboplatin Injection The risk or severity of adverse effects can be increased when Methimazole is combined with Carboplatin.
Lansoprazole	Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Methimazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Methimazole.
Pegaspargase Injection	Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Methimazole.
Bupropion	Bupropion The serum concentration of Bupropion can be increased when it is combined with Methimazole.
Ticlopidine	Ticlopidine The metabolism of Methimazole can be decreased when combined with Ticlopidine.
Metformin	Metformin Metformin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Dalteparin Injection	Dalteparin Injection Methimazole may increase the anticoagulant activities of Dalteparin.
Nisoldipine	Nisoldipine Nisoldipine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Lamivudine	Lamivudine Lamivudine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Riluzole	Riluzole The metabolism of Riluzole can be decreased when combined with Methimazole.
Acarbose	Acarbose Acarbose may decrease the excretion rate of Methimazole which could result in a higher serum level.
Glimepiride	Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methimazole.
Gemcitabine Injection	Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methimazole.
Ritonavir	Ritonavir The metabolism of Ritonavir can be decreased when combined with Methimazole.
Docetaxel Injection	Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Methimazole.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Meropenem may decrease the excretion rate of Methimazole which could result in a higher serum level.
Clomipramine	Clomipramine The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Clomipramine.
Zafirlukast	Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Methimazole.
Fosfomycin	Fosfomycin Methimazole may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine	Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Methimazole.
Topiramate	Topiramate Topiramate may decrease the excretion rate of Methimazole which could result in a higher serum level.
Zileuton	Zileuton The metabolism of Zileuton can be decreased when combined with Methimazole.
Valsartan	Valsartan The metabolism of Valsartan can be decreased when combined with Methimazole.
Pramipexole	Pramipexole Pramipexole may decrease the excretion rate of Methimazole which could result in a higher serum level.
Donepezil	Donepezil The metabolism of Donepezil can be decreased when combined with Methimazole.
Azithromycin	Azithromycin The metabolism of Azithromycin can be decreased when combined with Methimazole.
Carvedilol	Carvedilol The excretion of Carvedilol can be decreased when combined with Methimazole.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Flutamide	Flutamide The metabolism of Flutamide can be decreased when combined with Methimazole.
Selegiline	Selegiline The metabolism of Selegiline can be decreased when combined with Methimazole.
Bicalutamide	Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Methimazole.
Sertraline	Sertraline The metabolism of Methimazole can be decreased when combined with Sertraline.
Propafenone	Propafenone The excretion of Propafenone can be decreased when combined with Methimazole.
Letrozole	Letrozole The metabolism of Letrozole can be decreased when combined with Methimazole.
Irbesartan	Irbesartan The metabolism of Irbesartan can be decreased when combined with Methimazole.
Tamsulosin	Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Methimazole.
Ropinirole	Ropinirole The risk or severity of adverse effects can be increased when Methimazole is combined with Ropinirole.
Quetiapine	Quetiapine The serum concentration of Quetiapine can be increased when it is combined with Methimazole.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Methimazole which could result in a higher serum level.
Cetirizine	Cetirizine Cetirizine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Paroxetine	Paroxetine The metabolism of Paroxetine can be decreased when combined with Methimazole.
Tolcapone	Tolcapone Tolcapone may decrease the excretion rate of Methimazole which could result in a higher serum level.
Citalopram	Citalopram Methimazole may increase the QTc-prolonging activities of Citalopram.
Capecitabine	Capecitabine The metabolism of Capecitabine can be decreased when combined with Methimazole.
Efavirenz	Efavirenz The metabolism of Efavirenz can be decreased when combined with Methimazole.
Abacavir	Abacavir Methimazole may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil	Sildenafil The metabolism of Sildenafil can be decreased when combined with Methimazole.
Trastuzumab Injection	Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Methimazole.
Celecoxib	Celecoxib The metabolism of Celecoxib can be decreased when combined with Methimazole.
Rosiglitazone	Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Methimazole.
Tolterodine	Tolterodine The serum concentration of Tolterodine can be increased when it is combined with Methimazole.
Thalidomide	Thalidomide The risk or severity of adverse effects can be increased when Methimazole is combined with Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Methimazole which could result in a higher serum level.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Methimazole which could result in a higher serum level.
Nateglinide	Nateglinide The metabolism of Nateglinide can be decreased when combined with Methimazole.
Galantamine	Galantamine The metabolism of Galantamine can be decreased when combined with Methimazole.
Rabeprazole	Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Methimazole.
Terbinafine	Terbinafine The metabolism of Terbinafine can be decreased when combined with Methimazole.

Methimazole

On this page